{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:19Z","timestamp":1791923899733,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":237,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A single-centre open-label clinical research study enrolled 98 patients admitted with an episode of AHF who were randomized into two groups: (a) receiving SGLT2i once daily in addition to structured intravenous furosemide therapy; (b) receiving structured intravenous furosemide therapy alone. In-hospital congestion relief was evaluated by body weight change, EVEREST score, lung ultrasound B-lines, inferior vena cava ultrasound measurement, NT-proBNP and CD146. Safety was assessed by changes in renal function and serum electrolyte abnormalities. Secondary endpoints included diuresis and natriuresis, hospital care indices and echocardiographic changes in cardiac function at 1-month. ANCOVA analysis was performed to adjust for imbalance between the two groups regarding chronic kidney disease status and baseline values. The analysis followed an intention-to-treat approach. The mean age \u00b1 standard deviation in the SGLT2i and control group was 63.63 \u00b1 10.95 years and 65.31 \u00b1 10.82 years, respectively, with 40\/49 and 42\/49 males. No death occurred in hospital; 1\/49 and 2\/49 deaths at 30 days were recorded. The adjusted mean change \u00b1 standard error (SE) in body weight was \u22124.90 \u00b1 0.93 kg versus \u22124.28 \u00b1 0.81 kg in the SGLT2i and control group, respectively. The adjusted mean change \u00b1 SE in B-lines at discharge and at 1 month was \u221219.93 \u00b1 0.87 versus \u221218.64 \u00b1 0.79 (P = 0.227) and \u221219.65 \u00b1 1.54 versus \u221214.82 \u00b1 1.43 (P = 0.012), respectively. The proportion of worsening renal function was 15\/49 and 6\/47 (P = 0.048) in the respective treatment groups (SGLT2i and control). The adjusted mean \u00b1 SE of 24-h urinary Na was 248.03 \u00b1 23.69 mmol\/day versus 173.83 \u00b1 20.76 mmol\/day (P = 0.009). One-month changes in ultrasound parameters were significantly improved in the SGLT2i group, with median (inter-quartile range) values of left ventricular ejection fraction and end-diastolic volume equal to 5% (0.35% to 11.5%) versus 0 (\u22121% to +5%) and \u22126.5 mL (\u221227.5 to +3) versus 4 mL (\u221211.5 to +10), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early initiation of SGLT2i administration in addition to intravenous loop diuretics in patients with AHF would optimize congestion relief and improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15356","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:03:40Z","timestamp":1750932220000},"page":"3320-3332","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary Congestion Relief By Adding Dapagliflozin to Intravenous Loop Diuretic in Acute Heart Failure Patients"],"prefix":"10.1093","volume":"12","author":[{"given":"Daniela","family":"Mocan","sequence":"first","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Puschita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-1377","authenticated-orcid":false,"given":"Diana","family":"Lungeanu","sequence":"additional","affiliation":[{"name":"Center for Modeling Biological Systems and Data Analysis, \u2018Victor Babes\u2019 University of Medicine and Pharmacy , Timisoara ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Pop-Moldovan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Pilat","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Darabantiu","sequence":"additional","affiliation":[{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Jipa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Ioan","family":"Lala","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u2018Vasile Goldis\u2019 Western University , Arad ,","place":["Romania"]},{"name":"Arad County Clinical Emergency Hospital , Arad ,","place":["Romania"]},{"name":"Clinical Hospital of Infectious Diseases and Pneumonology \u2018Dr. Victor Babes\u2019 , Timisoara ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2026021804202532200_ehf215356-bib-0001","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0002","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0003","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/eurheartj\/ehad613","article-title":"Correction to: 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0004","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021804202532200_ehf215356-bib-0005","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.119.11684","article-title":"Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors","volume":"75","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"2026021804202532200_ehf215356-bib-0006","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021804202532200_ehf215356-bib-0007","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of dapagliflozin in patients with acute heart failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021804202532200_ehf215356-bib-0008","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0009","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1745-6215-11-32","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"11","author":"Schulz","year":"2010","journal-title":"Trials"},{"key":"2026021804202532200_ehf215356-bib-0010","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0011","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"2026021804202532200_ehf215356-bib-0012","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0013","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001613","article-title":"Lung ultrasound at discharge predicts outcomes in heart failure: a pilot study","author":"Perillo","year":"2024","journal-title":"J Cardiovasc Med"},{"key":"2026021804202532200_ehf215356-bib-0014","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajo.2003.11.028","article-title":"Dropout rates for intent-to-treat and per protocol analyses","volume":"137","author":"Stewart","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"2026021804202532200_ehf215356-bib-0015","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00273171.2016.1219841","article-title":"Power and sample size calculations for contrast analysis in ANCOVA","volume":"52","author":"Shieh","year":"2017","journal-title":"Multivar Behav Res"},{"key":"2026021804202532200_ehf215356-bib-0016","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1600764","article-title":"The ANCOVA model for comparing two groups: a tutorial emphasizing statistical distribution theory","volume":"16","author":"Schwarz","year":"2025","journal-title":"Front Psychol"},{"key":"2026021804202532200_ehf215356-bib-0017","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ"},{"key":"2026021804202532200_ehf215356-bib-0018","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/ejhf.344","article-title":"Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure","volume":"17","author":"Coiro","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026021804202532200_ehf215356-bib-0019","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ahj.2024.07.015","article-title":"Inferior vena CAVA and lung ultrasound-guided therapy in acute heart failure: a randomized pilot study (CAVAL US-AHF study)","volume":"277","author":"Burgos","year":"2024","journal-title":"Am Heart J"},{"key":"2026021804202532200_ehf215356-bib-0020","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"2026021804202532200_ehf215356-bib-0021","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/ejhf.2967","article-title":"Sodium\u2013glucose cotransporter-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies","volume":"25","author":"Biegus","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021804202532200_ehf215356-bib-0022","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCHEARTFAILURE.121.008365","article-title":"Enhanced expression and function of renal SGLT2 (sodium-glucose cotransporter 2) in heart failure: role of renal nerves","author":"Katsurada","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026021804202532200_ehf215356-bib-0023","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00125-015-3771-9","article-title":"Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats","volume":"58","author":"Rafiq","year":"2015","journal-title":"Diabetologia"},{"key":"2026021804202532200_ehf215356-bib-0024","doi-asserted-by":"publisher","first-page":"F969","DOI":"10.1152\/ajprenal.00551.2017","article-title":"SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism","volume":"314","author":"Layton","year":"2018","journal-title":"Am J Physiol-Ren Physiol"},{"key":"2026021804202532200_ehf215356-bib-0025","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/969","article-title":"Renal and intestinal absorptive defects in mice lacking the NHE3 Na+\/H+ exchanger","volume":"19","author":"Schultheis","year":"1998","journal-title":"Nat Genet"},{"key":"2026021804202532200_ehf215356-bib-0026","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1681\/ASN.2013060588","article-title":"Functional role of glucose metabolism, osmotic stress, and sodium-glucose cotransporter isoform-mediated transport on Na+\/H+ exchanger isoform 3 activity in the renal proximal tubule","volume":"25","author":"Pessoa","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026021804202532200_ehf215356-bib-0027","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1681\/ASN.2015111282","article-title":"MAP 17 is a necessary activator of renal Na+\/glucose cotransporter SGLT2","volume":"28","author":"Coady","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026021804202532200_ehf215356-bib-0028","doi-asserted-by":"publisher","first-page":"F718","DOI":"10.1152\/ajprenal.2001.281.4.F718","article-title":"Renal salt wasting in mice lacking NHE3 Na +\/H + exchanger but not in mice lacking NHE2","volume":"281","author":"Ledoussal","year":"2001","journal-title":"Am J Physiol-Ren Physiol"},{"key":"2026021804202532200_ehf215356-bib-0029","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","article-title":"Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"key":"2026021804202532200_ehf215356-bib-0030","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2021.814074","article-title":"The urinary glucose excretion by sodium\u2013glucose cotransporter 2 inhibitor in patients with different levels of renal function: a systematic review and meta-analysis","author":"Hu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021804202532200_ehf215356-bib-0031","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/ejhf.3423","article-title":"Decongestion in acute heart failure: is it time to change diuretic-centred paradigm?","volume":"26","author":"Biegus","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804202532200_ehf215356-bib-0032","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/eurheartj\/ehae300","article-title":"Great debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction","volume":"45","author":"Packer","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021804202532200_ehf215356-bib-0033","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamacardio.2020.6827","article-title":"Associations of Empagliflozin with left ventricular volumes, mass, and function in patients with heart failure and reduced ejection fraction","volume":"6","author":"Omar","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026021804202532200_ehf215356-bib-0034","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijcard.2015.07.039","article-title":"Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure","volume":"199","author":"Gayat","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026021804202532200_ehf215356-bib-0035","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00109-023-02392-7","article-title":"The role of CD146 in renal disease: from experimental nephropathy to clinics","volume":"102","author":"Boutin","year":"2024","journal-title":"J Mol Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/5\/3320\/66969704\/eschf_12_5_3320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/5\/3320\/66969704\/eschf_12_5_3320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:20:32Z","timestamp":1771406432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/5\/3320\/8488247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15356","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"2025-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}